Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: Results of a phase 1/2 study
Philip J. Mease, Nathan Wei, Edward J. Fudman, Alan J. Kivitz, Joy Schechtman, Robert G. Trapp, Kathryn F. Hobbs, Maria Greenwald, Antony Hou, Stephen A. Bookbinder, Galen E. Graham, Craig W. Wiesenhutter, Larry Willis, Eric M. Ruderman, Joseph Z. Forstot, Michael J. Maricic, Kathryn H. Dao, Charles H. Pritchard, Darrell N. Fiske, Francis X. BurchH. Malin Prupas, Pervin Anklesaria, Alison E. Heald
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: Results of a phase 1/2 study'. Together they form a unique fingerprint.